Target intelligence / Profile preview

G protein-coupled receptor 25 (GPR25)

Target
GPR25
Molecular classification
G protein-coupled receptor, Rhodopsin-like receptor, Receptor
01

Overview

G protein-coupled receptor 25 (GPR25) is an orphan receptor belonging to the class A (rhodopsin-like) family of G protein-coupled receptors[1][2][3][6][8]. GPR25 is encoded by an intronless gene and is highly conserved evolutionarily[1][2]. In humans, its expression is enriched in lymphocytes, natural killer (NK) cells, some T-cells, and to a lesser degree in the stomach[1][7]. Its biological functions are incompletely characterized, but evidence implicates GPR25 in signal transduction pathways affecting immune response and blood pressure regulation, with genetic association studies linking GPR25 to arterial stiffness and psoriasis[2][3][7]. GPR25 is classified as an orphan receptor because a definitive endogenous ligand in humans is not confirmed, though it can be activated by certain peptides in non-mammalian vertebrates and may have chemokine receptor-like properties[2][1]. No drugs are currently known to target GPR25, and there are no established biomarkers or safety concerns at this time.

Other names
Probable G-protein coupled receptor 25GPR25_HUMAN
02

Mechanism of action

Modulation of intracellular cAMP signaling; Possible chemokine receptor activity (as receptor for chemokine-like protein CXCL17; some evidence)

03

Biological functions

Signal transductionImmune responsePossible cardiovascular regulation
04

Disease associations

Cardiovascular disease (specifically associated with arterial stiffness and blood pressure regulation)PsoriasisPotential immune-related disorders

Beyond the preview

Go deeper on G protein-coupled receptor 25 (GPR25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-coupled receptor 25 (GPR25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call